IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DSGN

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents12.9112.7716.8615.0919.7013.6722.5630.3345.7029.4021.2027.9427.2028.8126.5042.52119.65287.31298.57357.66
Short-term Investments194.49210.05202.99190.88196.57216.01222.91223.75215.32241.29260.60263.00275.89286.58303.89301.72239.7283.9185.5036.06
Total Current Assets212.01227.05223.78209.03219.79233.64248.04257.24264.84273.89284.58294.54306.05318.94335.12348.49361.72373.87385.44395.29
Property, Plant & Equipment0.690.820.981.101.261.381.411.561.731.721.691.781.861.911.951.841.801.451.511.32
Total Non-current Assets*3.123.392.422.743.093.834.054.394.744.915.065.335.595.806.026.086.214.935.125.06
Total Assets215.13230.44226.20211.77222.89237.48252.09261.63269.58278.79289.64299.87311.63324.74341.14354.57367.93378.80390.56400.35
Accounts Payable3.142.282.311.911.013.182.191.471.301.371.942.211.922.743.032.622.071.901.622.22
Total Current Liabilities11.2410.1913.0611.178.758.248.467.436.397.099.6212.3912.139.0510.7810.417.395.485.285.51
Total Non-current Liabilities*2.032.200.650.881.101.321.531.741.952.142.332.522.702.883.053.223.383.013.143.28
Total Liabilities13.2712.3913.7012.059.859.5610.009.188.349.2411.9614.9114.8411.9313.8313.6310.778.498.438.79
Retained Earnings(334.81)(314.64)(297.01)(281.01)(264.01)(244.93)(227.21)(213.56)(200.52)(188.73)(177.63)(165.78)(149.99)(130.06)(110.76)(93.42)(75.72)(60.72)(47.46)(36.39)
Total Stockholder Equity201.86218.05212.50199.72213.04227.92242.10252.45261.24269.56277.69284.96296.80312.82327.31340.94357.16370.31382.13391.56
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.000.000.000.000.00------------------------0.030.02
Research & Development16.3914.3813.4314.5915.7415.3812.1611.8810.529.8011.0113.2617.0615.7314.2614.3011.308.767.348.54
Selling, General & Admin5.795.334.744.725.835.044.544.374.534.604.115.575.535.925.144.894.344.613.792.80
Total Operating Expenses22.1819.7118.1719.3121.5720.4216.6916.2515.0414.4015.1218.8222.6021.6519.3919.1915.6413.3711.1311.34
Operating Income(22.18)(19.71)(18.17)(19.31)(21.57)(20.42)(16.69)(16.25)(15.04)(14.40)(15.12)(18.82)(22.60)(21.65)(19.39)(19.19)(15.64)(13.37)(11.13)(11.34)
Net Income(20.16)(17.64)(16.00)(17.00)(19.08)(17.71)(13.65)(13.04)(11.79)(11.10)(11.84)(15.79)(19.94)(19.29)(17.34)(17.70)(15.00)(13.26)(11.06)(11.32)
Basic EPS(0.32)(0.29)(0.27)(0.30)(0.34)(0.31)(0.24)(0.23)(0.21)(0.20)(0.20)(0.28)(0.36)(0.35)(0.31)(0.32)(0.27)------
Diluted EPS(0.32)(0.29)(0.27)(0.30)(0.34)(0.31)(0.24)(0.23)(0.21)(0.20)(0.20)(0.28)(0.36)(0.35)(0.31)(0.32)(0.27)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(15.52)(16.43)(11.97)(11.16)(14.44)(16.79)(9.86)(9.55)(11.26)(12.44)(12.80)(14.53)(13.80)(17.42)(15.09)(13.90)(10.50)(11.83)(9.23)(8.16)
Capital Expenditures0.020.000.030.000.090.070.00(0.02)0.160.200.030.050.090.090.290.310.240.080.350.97
Free Cash Flow*(15.54)(16.43)(12.00)(11.16)(14.53)(16.86)(9.86)(9.53)(11.42)(12.63)(12.82)(14.59)(13.89)(17.51)(15.38)(14.21)(10.74)(11.90)(9.58)(9.13)
Investing Cash Flow15.06(7.59)(11.58)6.5120.127.871.83(5.83)27.3320.625.5615.2711.9819.73(1.06)(63.39)(156.96)0.41(50.06)(5.04)
Financing Cash Flow0.6119.9325.320.040.360.020.260.000.230.020.500.010.21--0.130.15(0.20)0.160.190.03
← Scroll for more columns →

* Derived from reported values